RT Book, Section A1 Case, James A. A1 Heller, Gary V. A2 Heller, Gary V. A2 Hendel, Robert C. SR Print(0) ID 1190155752 T1 Radiopharmaceuticals for Cardiovascular Imaging T2 Nuclear Cardiology: Practical Applications, 4e YR 2022 FD 2022 PB McGraw Hill LLC PP New York, NY SN 9781264257201 LK accesscardiology.mhmedical.com/content.aspx?aid=1190155752 RD 2024/03/28 AB KEY POINTSIdeal tracer kinetics is important in understanding the strengths and limitations of current and future tracers.Thallium-201 has excellent tracer kinetics but is limited by low-energy emission level and long half-life, and therefore is not recommended for routine clinical use.Technetium-based tracers offer improved image quality due to higher emission level and shorter half-life and are the radiopharmaceuticals of choice for single-photon emission computerized tomographic nuclear cardiology.The most common positron emission tomography tracer, 82Rb, is generator-derived radiopharmaceutical, with excellent blood flow characteristics and low radiation, making it suitable for most clinical practices.